As various pathogenic pathways contributing to MetS development culminate in an inflammatory state, this study assessed the serum levels of IL-10 and IL-1β cytokines regarding their role in the susceptibility to developing MetS and other clinical characteristics in an older population (over 60). The gene discussed is IL1B; the disease is metabolic syndrome.